Clin2
NCT05495906Possibly a fitRecruiting

Lower-dose HPV vaccine study for women with HIV

HPVHuman Papilloma VirusHuman Immunodeficiency Virus

Part of Immune system & allergy, Infections clinical trials.

This trial tests whether giving a lower dose of the HPV vaccine can still be effective and safe for women living with HIV. It may be helpful if you need HPV protection and the study’s dose schedule could reduce vaccine burden.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
275 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are living with HIV
  • You have a cervix (uterine cervix)
  • You can fully understand the study and give consent
  • You are not currently pregnant and you can avoid pregnancy during vaccination
  • You are not allergic to this HPV vaccine or any of its ingredients
  • You have not received any HPV vaccine in the past

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05266898Recruiting· Phase 4
HPV vaccine response study for people living with HIV

This trial studies how well the Gardasil-9 HPV vaccine triggers the body’s immune response in people living with HIV. It may help doctors understand the best way to protect against HPV-related cancers and infections in this population.

New Orleans, Louisiana
NCT06144229Enrolling by invitation
HPV Vaccine in Women with HIV

This study looks at how well the HPV vaccine works in women living with HIV and whether it helps make cervical cancer screening more accurate. If you are a woman with HIV between 21 and 40 years old and already part of certain other HIV studies, you may be able to join.

Denver, Colorado
NCT06799494Recruiting· Phase 4
HPV vaccine: testing a reduced dose schedule

This study tests if giving fewer doses of the HPV vaccine still protects against HPV-related cancers. It may help people who are willing to get a reduced number of shots.

Decatur, Georgia
NCT06624839Recruiting· Phase 2
HPV vaccine study for people with and without HIV

This study tests how well the Gardasil 9 HPV vaccine works in people assigned male at birth, including those with HIV and those taking hormone therapy. Results could help protect against HPV-related cancers.

Washington D.C., District of Columbia
NCT07303751Not yet recruiting· Phase 2
HPV vaccine trial to reduce virus spread in women

This study tests if a single dose of the HPV vaccine (Gardasil 9) can lower the amount of HPV virus in women who already have the virus, potentially reducing how easily it spreads. It will help us learn if vaccination can protect partners and communities.

Freetown
NCT06220747Recruiting
HPV vaccine study for women ages 12 to 45

This study tests how well the HPV vaccine works in women and teens. It's for those who are willing to get an HPV test and haven't already had all 3 doses of the vaccine.

Bangkok, Select...

Hear when a new HPV trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.